OTOF Gene Therapy

Single Gene Therapy Injection Reverses Deafness Across Age Groups

Karolinska Institutet’s first-in-human use of an adeno-associated virus to deliver OTOF directly into inner ear tissues restored hearing thresholds from 106 to 52 decibels in patients aged 1 to 24 within months without serious adverse reactions